Format

Send to

Choose Destination
Methods Mol Biol. 2011;682:77-87. doi: 10.1007/978-1-60327-409-8_7.

5'OH DNA breaks in apoptosis and their labeling by topoisomerase-based approach.

Author information

1
Departments of Neurosurgery and Molecular & Cellular Biology, Baylor College of Medicine, and Michael E. DeBakey VA Medical Center, Houston, TX, USA. vdidenko@bcm.edu

Abstract

Recently, the concept of apoptotic cell elimination was expanded and programed cell death is no longer viewed as an individual cellular event. The complete description of the apoptotic process now includes two phases: the self-driven cell disassembly and the externally-controlled elimination of apoptotic cell corpses by phagocytizing cells. The second, phagocytic phase is essential, highly conserved, and is even more important than the internal phase of cell disassembly. This is because it ensures the complete degradation of the dying cell's DNA, preventing the release of pathological, viral and tumor DNA, and self-immunization. In different cells and species from mammals to flies, a single conserved enzyme--DNase II is responsible for the elimination of cellular DNA in the second "mopping up" phase of apoptosis. Here, we present an assay for the selective detection of the phagocytic phase of apoptosis. The technology capitalizes on the fact that phagocytic DNase II produces identifiable signature DNA breaks, which can be labeled by vaccinia topoisomerase. The assay permits labeling of the previously underestimated phase of apoptotic execution and is a useful tool in the apoptosis detection arsenal.

PMID:
21057922
PMCID:
PMC3324587
DOI:
10.1007/978-1-60327-409-8_7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center